evolocumab
pharmaceutical drug
Press Enter · cited answer in seconds
0 sources
evolocumab
Summary
evolocumab is a type of chemical entity[1]. evolocumab ranks in the top 4% of type_of_chemical_entity entities by monthly Wikipedia readership (205 views/month).[2]
Key Facts
- evolocumab's instance of is recorded as type of chemical entity[3].
- evolocumab's physically interacts with is recorded as Proprotein convertase subtilisin/kexin type 9[4].
- evolocumab's manufacturer is recorded as Amgen[5].
- evolocumab's CAS Registry Number is recorded as 1256937-27-5[6].
- evolocumab's ATC code is recorded as C10AX13[7].
- evolocumab's subclass of is recorded as chemical compound[8].
- evolocumab's has use is recorded as medication[9].
- evolocumab's MeSH descriptor ID is recorded as C577155[10].
- evolocumab's ChEMBL ID is recorded as CHEMBL2364655[11].
- evolocumab's Guide to Pharmacology Ligand ID is recorded as 7343[12].
- evolocumab's Freebase ID is recorded as /m/0w7q9yh[13].
- evolocumab's UNII is recorded as LKC0U3A8NJ[14].
- evolocumab's DrugBank ID is recorded as DB09303[15].
- evolocumab's has characteristic is recorded as biopharmaceutical[16].
- evolocumab's HSDB ID is recorded as 8307[17].
- evolocumab's NDF-RT ID is recorded as N0000192016[18].
- evolocumab's medical condition treated is recorded as lipedema[19].
- evolocumab's medical condition treated is recorded as heart disease[20].
- evolocumab's medical condition treated is recorded as arteriosclerosis[21].
- evolocumab's medical condition treated is recorded as hyperlipoproteinemia type V[22].
- evolocumab's medical condition treated is recorded as rare dyslipidemia[23].
- evolocumab's medical condition treated is recorded as coronary artery disease[24].
- evolocumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'evolocumab'}[25].
- evolocumab's subject has role is recorded as anticholesteremic agents[26].
- evolocumab's subject has role is recorded as monoclonal antibody[27].
Why It Matters
evolocumab ranks in the top 4% of type_of_chemical_entity entities by monthly Wikipedia readership (205 views/month).[2] evolocumab has Wikipedia articles in 15 language editions, a strong signal of global cultural recognition.[28]